Neuroscience
Pharmafocus reported earlier in the week about a plan by Pfizer to roll out some social networking options for patients considering clinical-trial participation:
Pfizer to develop online community to find new trials patients
Monday , August 24, 2009
Read the report.
The report indicates that Pfizer has teamed with Private Access in this product.
I know I have been involved in co-hosting online communities for Alzheimer's disease and in oncology and such online communities can be very exciting for patients, caregivers, and scientists.
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Uc San Francisco-pfizer Drug Development Partnership
From EurekaAlert: UCSF-Pfizer partnership yields projects aimed at clinical trials 26 October 2011 Read the full article...
- Alzheimer Disease: Dimebon Results
A press release from earlier today by Pfizer: Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine) Alzheimer’s Disease Clinical Development Program [snip] "About the CONNECTION Study "CONNECTION is a Phase 3, multi-national,...
- Quality Assurance In Clinical Trials
Public release date: 21-Sep-2008 American Society for Therapeutic Radiology and Oncology Quality assurance programs improve clinical trials Boston – Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester,...
Neuroscience
Clinical Trials: Social Networking for Recruitment and Feedback
Pharmafocus reported earlier in the week about a plan by Pfizer to roll out some social networking options for patients considering clinical-trial participation:
Pfizer to develop online community to find new trials patients
Monday , August 24, 2009
Read the report.
The report indicates that Pfizer has teamed with Private Access in this product.
I know I have been involved in co-hosting online communities for Alzheimer's disease and in oncology and such online communities can be very exciting for patients, caregivers, and scientists.
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Uc San Francisco-pfizer Drug Development Partnership
From EurekaAlert: UCSF-Pfizer partnership yields projects aimed at clinical trials 26 October 2011 Read the full article...
- Alzheimer Disease: Dimebon Results
A press release from earlier today by Pfizer: Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine) Alzheimer’s Disease Clinical Development Program [snip] "About the CONNECTION Study "CONNECTION is a Phase 3, multi-national,...
- Quality Assurance In Clinical Trials
Public release date: 21-Sep-2008 American Society for Therapeutic Radiology and Oncology Quality assurance programs improve clinical trials Boston – Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester,...